VMAX - ETF AI Analysis
Top Page
Hartford US Value ETF (VMAX)
VMAX, the Hartford US Value ETF, appears to be a solid, quality-focused fund, helped by strong holdings like Progressive, Bristol-Myers Squibb, and Prudential Financial, which bring robust financial performance, attractive valuations, and supportive earnings call trends. Large positions in companies such as Visa, Mastercard, Meta, and Berkshire Hathaway add long-term growth potential but also introduce risks around high valuations, bearish technical trends, and company-specific challenges, making sector and stock-level concentration an important factor to watch.
VMAX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.29M
- Region
- North America
- Expense Ratio
- 0.29%
- Beta
- 0.77
- Issuer
- Hartford
- Inception Date
- Dec 06, 2023
- Dividend Yield
- 2.05%
- Asset Class
- Equity
- Index Tracked
- Hartford US Value Index - Benchmark TR Gross
VMAX Summary
Hartford US Value ETF (VMAX) is an exchange-traded fund that follows the Hartford US Value Index, focusing on large, established U.S. companies considered “value” stocks. It mainly holds financial, health care, and energy firms, including well-known names like Visa, Mastercard, Berkshire Hathaway, and Target. Investors might consider VMAX for diversification and potential long-term growth from solid, blue-chip companies that may be priced lower than their business strength suggests. However, this ETF can go up and down with the overall stock market, and its value focus may lag fast-growing tech or trendy sectors at times.
How much will it cost me?
This ETF has an annual expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 invested. That cost is a bit higher than many broad, passively managed index ETFs because this fund is actively managed to select specific U.S. large-cap value stocks.
What would affect this ETF?
Future performance of the Hartford US Value ETF could benefit from a strong U.S. economy, stable or falling interest rates, and healthy profits in its key sectors like financials, energy, and health care, which support major holdings such as Visa, Mastercard, and Berkshire Hathaway. On the other hand, rising interest rates, weaker consumer spending, tighter financial regulations, or pressure on large U.S. companies from new rules or technology shifts could hurt the value of its mostly U.S.-focused, large-cap portfolio.
VMAX Top 10 Holdings
VMAX leans heavily into U.S. financial and blue-chip value names, with Berkshire Hathaway, Prudential, Visa, and Mastercard acting as the fund’s financial backbone. Lately, the card networks have been a bit choppy, with bearish momentum occasionally weighing on returns, while Berkshire has been more steady than exciting. Meta adds a splash of Big Tech growth, helping performance as its AI story gains traction, and Target’s strong rebound has quietly boosted results. Overall, it’s a U.S.-centric, value-driven portfolio where financials call most of the shots.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 EOG | EOG Resources | 2.24% | $73.82K | $84.50B | 50.87% | 78Outperform |
 ELV | Elevance Health | 2.01% | $65.99K | $91.07B | 23.07% | 76Outperform |
 V | Visa | 1.97% | $64.67K | $750.29B | 15.54% | 70Outperform |
 MA | Mastercard | 1.88% | $61.96K | $534.23B | 6.55% | 75Outperform |
 PGR | Progressive | 1.90% | $62.36K | $131.10B | 4.16% | 78Outperform |
 BRK.B | Berkshire Hathaway B | 1.90% | $62.54K | $1.16T | 11.25% | 66Neutral |
 TGT | Target | 1.74% | $57.33K | $67.24B | 51.39% | 70Neutral |
 ALL | Allstate | 1.81% | $59.64K | $63.65B | 30.28% | 74Outperform |
 BMY | Bristol-Myers Squibb | 1.76% | $58.04K | $125.73B | 41.85% | 78Outperform |
 PRU | Prudential Financial | 1.73% | $56.85K | $39.75B | 12.72% | 77Outperform |
VMAX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VMAX, the sentiment is Positive. The current price of 65.65 is above the 20-day moving average (MA) of 64.22, above the 50-day MA of 64.25, and above the 200-day MA of 60.16, indicating a bullish trend. The MACD of 0.62 indicates Negative momentum. The RSI at 62.96 is Neutral, neither overbought nor oversold. The STOCH value of 68.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VMAX.
VMAX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VMAX | $65.65 | $71.00(8.15% Upside) | $3.29M | 0.29% | 73Outperform |
 PRXV | $36.20 | $41.71(15.21% Upside) | $94.51M | 0.36% | 72Outperform |
 MAVF | $138.38 | $166.89(20.60% Upside) | $90.86M | 0.75% | 75Outperform |
 STXV | $39.54 | $44.76(13.21% Upside) | $77.54M | 0.18% | 71Outperform |
 NSIV | $26.17 | $29.70(13.48% Upside) | $73.81M | 0.38% | 72Outperform |
 PZLV | $31.28 | $35.57(13.71% Upside) | $72.30M | 0.60% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VMAX | Hartford US Value ETF | 65.65 | 13.43 | 25.72% | |
| PRXV | Praxis Impact Large Cap Value ETF | 36.20 | 7.27 | 25.12% | |
| MAVF | Matrix Advisors Value ETF | 138.38 | 20.56 | 17.45% | |
| STXV | Strive 1000 Value ETF | 39.53 | 7.96 | 25.20% | |
| NSIV | North Square Disciplined Value ETF | 26.17 | 1.08 | 4.31% | |
| PZLV | Pzena U.S. Large Cap Value ETF | 31.28 | 6.18 | 24.60% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.